Navigation Links
Cardea Bio and Nanosens Innovations Inc. Merger-Acquisition Finalized
Date:10/10/2019

Cardea is excited to announce the finalization of their merger-acquisition of Nanosens Innovations, Inc., the creators of CRISPR-Chip™. Cardea first broke the news of the proposed merger in September, along with the announcement of their Early Access Program for the Genome Sensor™. Built with CRISPR-Chip technology, the Genome Sensor is the world’s first DNA search engine. It can google genomes to detect genetic mutations and variations.

Merging the two companies allows the power of Nanosens’ CRISPR-Chip technology to be combined with Cardea’s graphene biosensor infrastructure. This enables Cardea to build an advanced DNA version of its “biology-based transistors” which would otherwise normally work with proteins. Via the “Powered by Cardea” strategy, a series of new CRISPR-Chip DNA-focused products will be developed and marketed via Cardea’s partnerships with large companies in different markets.

“We are thrilled to announce that both companies’ Board of Directors and Shareholders have strongly supported the merger by voting yes to combining the two companies. I’d like to thank everyone who has made this possible. We here at Cardea are excited to expand our team?of talents with the talents from?Nanosens,”?says Cardea’s CEO, Michael?Heltzen.?

Nanosens will continue as a Cardea brand for the Genome Sensor and other tools made for the research market. They are currently accepting applications to the Genome Sensor Early Access Program where a select few will have exclusive access to the Genome Sensor before the rest of the world.

“With?Nanosens?as our internal Innovation Partner,?and?a handful of external Innovation Partnerships soon to be signed, we are ready to take in the investments we have been offered and scale up Cardea. This will take us to the next level on our venture to build the biology-based transistor?company that allows for people to connect computers directly with biology,”?continues?Heltzen.?

Cardea is actively looking for companies to partner with and co-develop new products through their Innovation Partnership Program. Partners will be able to utilize the unique features of Cardea’s “biology-based transistors” for future products. These features include near real-time detection, outside-the-lab DNA detection, and handheld user-friendly devices that enable insight to the biology systems in and around us. For more info, please visit http://www.cardeabio.com

Read the full story at https://www.prweb.com/releases/cardea_bio_and_nanosens_innovations_inc_merger_acquisition_finalized/prweb16635046.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Cardea Bio and Nanosens Innovations Look to Combine Companies
2. Nanosensors could aid drug manufacturing
3. Biologists develop nanosensors to visualize movements and distribution of plant hormone
4. Mount Sinai celebrates team science at second-annual SINAInnovations Conference Nov. 18-19, 2013
5. Ben-Gurion U. and UChicago research collaboration targets water resource innovations
6. Innovations save lives of mothers and children
7. 83 global health innovations receive Grand Challenges Canada funding
8. NREL expert honored for energy systems innovations
9. NREL staff recognized for top innovations
10. NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
11. NSF and NIH collaborate to accelerate advance of biomedical innovations into the marketplace
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2019)... ... 03, 2019 , ... Mount Sinai researchers have discovered how the enzyme DNA ... to the next. In a study published in Nature Structural & Molecular Biology, the ... to cancers and other diseases. , “DNA polymerase delta serves as the duplicating machine ...
(Date:10/3/2019)... , ... October 02, 2019 , ... Personalized Stem ... first patient in an FDA approved clinical trial for stem cell treatment of ... after formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, ...
(Date:9/30/2019)... ... September 30, 2019 , ... ... on molecular manufacturing and other transformative technologies, announced the winners for the 2019 ... and the other for Theory in nanotechnology/molecular manufacturing. , Established in 1993 and ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... As World ... middle school and high school students have improved neuro-cognitive executive skills to enhance ... physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, due to ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... ... of low level laser therapy technology (“3LT®”), today announces that the U.S. Food ... its EVRL low level laser for the temporary relief of chronic neck and ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked ... that is enabling clinical program outsourcing success by cultivating radical improvements in leadership, ... biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise ...
(Date:10/3/2019)... ... October 03, 2019 , ... Yesterday, at the 2019 meeting of ... and director, James L. Sherley, M.D., Ph.D., discussed important design factors that currently limit ... including both developers and suppliers of clinical trials, in his talk Dr. ...
Breaking Biology Technology: